The abstinence syndrome which follows withdrawal of opiates is the prototype of drug withdrawal reaction and is one of the several factors promoting addiction.
Although management of this syndrome is but a small part of treatment of an addict, it is nonetheless an important one. Recent studies have shown that a single dose of Clonidine hydrochloi ide (ARKAMIN) relieves signs and symptoms of opiate withdrawal and that addicts can be successfully detoxified with Clonidine.
The rationale for testing Glonidine's efficacy in opiate withdrawal was based on animal studies showing that increased brain noradrenergic activity associated with opiate withdrawal was markedly reduced by Clonidine (Washton et ah, 1980 The patient was admitted and Morphine was completely discontinued from the day of hospitalization. For the first two days, he was put on inj. pethidine 100 mg twice a day, inj. diazepam 10 mg twice daily and a hypnotic at bed time. Patient developed severe withdrawal symptoms in the form of irritability, sleeplessness, lethargy, chills, rhinorrhoea, restlessness, abdominal cramps, nausea and diarrhoea. From the third day of hospitalization, he was started on tab. Clonidine 0.1 mg 6 hourly (all other drugs were stopped). The dose of Clonidine was increased by one tablet everyday upto a maximum of 0.9 mg per day. Regular checkup of blood pressure was done and the patient did not develop any postural hypotension. Paiicnt showed remarkable improvement on the veiy next day of starling Clonidine, and he became asymptomatic within 5 days. Patient was maintained on a dose of 0.9 mg of Clonidine per day for the next 10 days. Over the next 5 days, dose of Clonidine was reduced at the rate of 2 tablets per day. Patient became drug free on 20th day of treatment and he was totally asymptomatic National Institute of Mental Health & Neuro Sciences, Bangalore-560 029.
at that time. Patient was kept in the hospital for the next 5 days without any drugs and later he was discharged.
DISCUSSION
Clonidine (available in India as ARK.AMIN 0.1 mg tablets) is an effective drug in controlling opiate withdrawal symptoms. Several studies suggest that Clonidine may be superior to Methadone in controlling morphine abstinence syndrome (Gold elal., 1980; Washton et al., 1980) . In order to achieve a safe and effective control of withdrawal symptoms with Clonidine, the dose regimen must be individualized according to each patient's blood pressure and symptomatology.
